Dr. Martens (LON:DOCS) Trading Down 9.6% – Time to Sell?

Dr. Martens plc (LON:DOCS) shares fell 9.6% on Friday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares traded hands during mid-day trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analysts Set New Price Targets

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Dr. Martens in a research note on Thursday. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of GBX 6,000.

Dr. Martens Trading Down 0.7%

The business has a 50 day simple moving average of GBX 89.93 and a 200-day simple moving average of GBX 80.61. The stock has a market capitalization of £707.84 million, a price-to-earnings ratio of 146.50, a PEG ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS) last released its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, equities analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insider Buying and Selling at Dr. Martens

In other news, insider Giles Wilson sold 30,000 shares of the stock in a transaction on Monday, September 1st. The shares were sold at an average price of GBX 91, for a total transaction of £27,300. Also, insider Ije Nwokori sold 298,675 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. In the last three months, insiders have bought 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. 2.80% of the stock is owned by corporate insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.